PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 11145025-1 2000 OBJECTIVE: To assess the effect of interferon-gamma (IFNgamma) administration on the evolution of systemic infection and septic arthritis induced by group B streptococci (GBS) in mice. gbs 171-174 interferon gamma Mus musculus 35-51 11145025-1 2000 OBJECTIVE: To assess the effect of interferon-gamma (IFNgamma) administration on the evolution of systemic infection and septic arthritis induced by group B streptococci (GBS) in mice. gbs 171-174 interferon gamma Mus musculus 53-61 11145025-9 2000 CONCLUSION: The findings of this study demonstrate that the effects mediated by IFNgamma on GBS-induced arthritis may be detrimental or beneficial, depending on the time of administration of IFNgamma in relation to infection with the antigen. gbs 92-95 interferon gamma Mus musculus 80-88 11145025-9 2000 CONCLUSION: The findings of this study demonstrate that the effects mediated by IFNgamma on GBS-induced arthritis may be detrimental or beneficial, depending on the time of administration of IFNgamma in relation to infection with the antigen. gbs 92-95 interferon gamma Mus musculus 191-199 8606095-1 1996 The existence of interleukin-12-mediated innate immune responses to group B streptococci (GBS) was tested by examining T-lymphocyte-independent gamma interferon (IFN) production in cultured splenocytes from severe combined immunodeficiency mice. gbs 90-93 interferon gamma Mus musculus 144-166 8606095-7 1996 The results show that extracellular pathogens such as GBS, similarly to intracellular microbes, induce macrophage interleukin-12 and tumor necrosis factor alpha, which promote natural killer cell secretion of IFN, which then enhances innate phagocyte resistance mechanisms. gbs 54-57 interferon gamma Mus musculus 209-212 8606095-3 1996 Type III GBS as well as other extracellular bacterial agents of neonatal sepsis (staphylococci and enterococci) induced IFN production, which was enhanced by interleukin-2 and was inhibited by neutralizing antibodies to tumor necrosis factor alpha and to mouse interleukin-12. gbs 9-12 interferon gamma Mus musculus 120-123